HRCM
NEO icon

Hood River Capital Management’s NeoGenomics NEO Stock Holding History

Hood River Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-341,936
Closed -$3.24M – 165
2025
Q1 		$3.24M Buy
+341,936
New +$4.27M 0.06% 133
2024
Q1 		– Sell
-734,714
Closed -$11.9M – 143
2023
Q4 		$11.9M Buy
+734,714
New +$12M 0.33% 82

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Hood River Capital Management's NEO Position: Q2 2025 in Review

Hood River Capital Management sold out of NeoGenomics (NEO) in Q2 2025, closing a stake of 341,936 shares — an estimated $3.24M sold.

Hood River Capital Management first reported a position in NEO in Q4 2023 and held it in 2 quarters. The position peaked at $11.9M in Q4 2023. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

  • Hood River Capital Management reported no remaining NeoGenomics position as of Q2 2025 after selling out during the quarter.
  • Hood River Capital Management sold 341,936 NeoGenomics shares in Q2 2025, an estimated $3.24M.
  • Hood River Capital Management first reported a position in NeoGenomics in Q4 2023 and held it in 2 quarters.
  • Hood River Capital Management's NeoGenomics position peaked at $11.9M in Q4 2023.
  • 274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on Hood River Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.